- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04378322
Sustainable Weight Loss Study: Nutrition Support Tools and Weight Loss Among Obese People
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Obesity is a major public health burden. Weight loss among obese participants may improve future health outcomes and financial burden to the healthcare system and employers.
The effect of personalized meal planning and online food purchasing and delivery on weight loss and management is unknown.
Design: This trial is an online, three-arm randomized trial to compare a meal planning and telenutrition tool, a meal planning tool only, and MyPlate optimization.
Participants will be assigned to randomly assigned in a 1:1:1 ratio to one of the three groups.
Participants will follow the intervention for 6 months after randomization and will be followed for an additional 1.5 years after randomization.
Participants will report dietary behavior and weight at baseline and each month of the intervention (6 months), 12 months, 18 months, and 24 months.
Population Approximately 300 participants will be enrolled and randomized (100 per arm). Participants will be adults living in New York state who are obese (at least a BMI of 30 kg/m2).
Outcomes Primary outcome: weight change after 6 months Other outcomes: waist circumference; blood pressure, dietary changes, cooking, meal planning, and eating out frequencies
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
BMI ≥ 30 kg/m2 Male or female 18 or older Non-institutionalized Able and willing to provide informed consent Willing to change diet for 3 months Has access to a scale to weigh themselves Lives in NY state
Exclusion Criteria:
Refuse or are unable to provide informed consent to participate in the study Undergoing active cancer treatment Has type 1 or 2 diabetes Stage 3+ CKD or kidney failure Are pregnant or breastfeeding, have given birth in the last three months, or are planning to be pregnant in the next 3 months Report of congestive heart failure Diagnosed with an eating disorder (e.g. anorexia nervosa or bulimia nervosa) Current or former Zipongo users
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Nutrition and food purchasing tool + telenutrition
Participants will use an online nutrition and food purchasing tool in addition to telenutrition.
|
Participants will be asked to use a meal planning and food purchasing feature regularly (at least once every two weeks) and schedule appointments with a registered dietitian.
|
|
Aktiv komparator: Nutrition and food purchasing tool
Participants will use an online nutrition and food purchasing tool.
|
Participants will be asked to use a meal planning and food purchasing feature regularly (at least once every two weeks).
|
|
Aktiv komparator: Nutrition education tool
Participants will be exposed to an online nutrition education materials.
|
Participants will be asked to review nutrition education materials online.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Weight change
Tidsram: Baseline and end of months 1, 2, 3, 4, 5, 6, 12, 18, and 24
|
Weight will be measured using a scale and self-reported.
|
Baseline and end of months 1, 2, 3, 4, 5, 6, 12, 18, and 24
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Waist circumference
Tidsram: Baseline and end of months 1, 2, 3, 4, 5, 6, 12, 18, and 24
|
Waist circumference will be measured using a tape measure and self-reported.
|
Baseline and end of months 1, 2, 3, 4, 5, 6, 12, 18, and 24
|
|
Blood pressure
Tidsram: Baseline and end of months 1, 2, 3, 4, 5, 6, 12, 18, and 24
|
Blood pressure will be a self-reported assessment at a clinic or pharmacy.
|
Baseline and end of months 1, 2, 3, 4, 5, 6, 12, 18, and 24
|
|
Change in diet quality
Tidsram: Baseline and end of months 1, 2, 3, 4, 5, 6, 12, 18, and 24
|
Diet quality will be assessed using a food frequency questionnaire.
|
Baseline and end of months 1, 2, 3, 4, 5, 6, 12, 18, and 24
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Förväntat)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 102
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .